Article Text

PDF
Correction

Statistics from Altmetric.com

In our article Indacaterol for COPD (DTB 2011; 50: 58–60) we included the statement: “This recommends a short-acting inhaled bronchodilator (either a beta2 agonist or short-acting muscarinic antagonist) as initial therapy for the relief of breathlessness and for reducing exercise limitation, with the addition of long-acting bronchodilators and/or an inhaled corticosteroid for people who remain breathless or have exacerbations.” Thank you to commentators who pointed out that it should have read “with the addition of long-acting bronchodilators and an inhaled corticosteroid for people who remain breathless or have exacerbations.”1

References

View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Articles
    BMJ Publishing Group Ltd